Compound Evidence File
#EC-2026-0139
MT-1
Filed under Peptides. The bureau holds 180 laboratory returns for this compound from 78 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
78 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 5 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 4 | 10.0 | 10.0 | 10.0 | 24 May 2026 | 24 May 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 10.0 | 9.9 | 10.0 | 22 May 2026 | 7 Jul 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 4 | 10.0 | 9.9 | 10.0 | 13 Mar 2026 | 20 Jun 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 4 | 10.0 | 9.9 | 10.0 | 7 Mar 2026 | 19 Jun 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 4 | 10.0 | 9.9 | 10.0 | 16 Feb 2026 | 22 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 10.0 | 9.9 | 10.0 | 17 Nov 2025 | 7 May 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 3 | 10.0 | 9.9 | 10.0 | 23 Feb 2026 | 21 May 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 3 | 10.0 | 9.9 | 10.0 | 16 Feb 2026 | 6 Apr 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 3 | 10.0 | 9.9 | 10.0 | 9 Nov 2025 | 8 Apr 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 10.0 | 9.9 | 10.0 | 25 Jun 2026 | 3 Jul 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 3 | 10.0 | 9.9 | 10.0 | 13 Feb 2026 | 24 May 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 2 | 10.0 | 10.0 | 10.0 | 12 May 2026 | 21 Jun 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 2 | 10.0 | 10.0 | 10.0 | 19 May 2026 | 7 Jun 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 9.9 | 9.9 | 9.9 | 23 Dec 2025 | 12 Jun 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 4 | 9.9 | 9.9 | 10.0 | 23 May 2026 | 8 Aug 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 4 | 9.9 | 9.9 | 10.0 | 4 Dec 2025 | 22 Jul 2026 |
| SinoPepCASE #VI-2026-0387 | A | 4 | 9.9 | 9.9 | 10.0 | 7 Apr 2026 | 7 Aug 2026 |
| AsymchemCASE #VI-2026-0091 | A | 4 | 9.9 | 9.9 | 10.0 | 9 Jan 2026 | 17 Jul 2026 |
| BachemCASE #VI-2026-0314 | A | 3 | 9.9 | 9.9 | 10.0 | 11 May 2026 | 1 Jul 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 2 | 9.9 | 9.9 | 10.0 | 3 May 2026 | 7 Jul 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 2 | 9.9 | 9.9 | 10.0 | 21 Mar 2026 | 21 Jun 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 2 | 9.9 | 9.9 | 9.9 | 22 Jan 2026 | 25 May 2026 |
| The Naughty NeedleCASE #VI-2026-0432 | X | 1 | 9.3 | 9.3 | 9.3 | 14 Jan 2025 | 14 Jan 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 2 | 9.1 | 9.1 | 9.2 | 25 May 2026 | 25 May 2026 |
| Yiwu Aozuo Trading CoCASE #VI-2026-0798 | X | 4 | 9.1 | 8.6 | 10.0 | 9 Jun 2025 | 24 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 6 | 9.0 | 8.0 | 10.0 | 25 May 2026 | 25 May 2026 |
| PurePeptidesCASE #VI-2026-0234 | X | 1 | 9.0 | 9.0 | 9.0 | 17 Dec 2024 | 17 Dec 2024 |
| Huaian Hanyou PeptideCASE #VI-2026-0297 | X | 1 | 8.7 | 8.7 | 8.7 | 20 Jun 2025 | 20 Jun 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 5 | 8.6 | 7.8 | 9.6 | 21 May 2026 | 21 May 2026 |
| InjectifyCASE #VI-2026-0387 | X | 2 | 8.6 | 7.7 | 9.4 | 27 Feb 2025 | 23 May 2026 |
| HazelCASE #VI-2026-0392 | X | 1 | 8.6 | 8.6 | 8.6 | 20 Jun 2025 | 20 Jun 2025 |
| Laicuinuo LCNCASE #VI-2026-0223 | X | 1 | 8.4 | 8.4 | 8.4 | 2 Jul 2025 | 2 Jul 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 6 | 8.3 | 7.4 | 9.4 | 25 May 2026 | 25 May 2026 |
| Peptide HavenCASE #VI-2026-0898 | X | 1 | 8.2 | 8.2 | 8.2 | 2 Jul 2025 | 2 Jul 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 4 | 8.1 | 6.8 | 9.2 | 25 May 2026 | 25 May 2026 |
| Shanghai JinBei Chemical TechnologyCASE #VI-2026-0107 | X | 1 | 8.0 | 8.0 | 8.0 | 16 Mar 2025 | 16 Mar 2025 |
| NextGen HealthCASE #VI-2026-0604 | X | 1 | 8.0 | 8.0 | 8.0 | 13 Feb 2025 | 13 Feb 2025 |
| Verified PeptidesCASE #VI-2026-0407 | X | 2 | 7.8 | 7.6 | 8.0 | 6 May 2025 | 17 May 2026 |
| Amino AmigosCASE #VI-2026-0061 | X | 3 | 7.7 | 5.8 | 8.7 | 9 Jun 2025 | 26 Jan 2026 |
| Planet PeptideCASE #VI-2026-0092 | X | 3 | 7.6 | 6.0 | 8.7 | 7 May 2025 | 24 May 2026 |
| Top PeptideCASE #VI-2026-0721 | X | 2 | 7.6 | 7.4 | 7.7 | 21 May 2025 | 20 May 2026 |
| Polaris PeptidesCASE #VI-2026-0839 | X | 1 | 7.5 | 7.5 | 7.5 | 9 Jun 2025 | 9 Jun 2025 |
| Chimera PeptidesCASE #VI-2026-0260 | X | 1 | 7.3 | 7.3 | 7.3 | 2 Apr 2025 | 2 Apr 2025 |
| Dragon PharmaCASE #VI-2026-0519 | X | 1 | 7.1 | 7.1 | 7.1 | 3 Jun 2025 | 3 Jun 2025 |
| Zhejiang Yichenkang BiotechnologyCASE #VI-2026-0269 | X | 2 | 7.0 | 5.5 | 8.6 | 8 Jul 2025 | 26 Jan 2026 |
| Henan Sahe PeptideCASE #VI-2026-0894 | X | 1 | 7.0 | 7.0 | 7.0 | 3 Jun 2025 | 3 Jun 2025 |
| HXNetCASE #VI-2026-0061 | X | 6 | 6.9 | 3.9 | 8.7 | 9 Jun 2025 | 21 May 2026 |
| Alpha-GenCASE #VI-2026-0905 | X | 3 | 6.9 | 6.4 | 7.5 | 3 Jun 2025 | 26 Jan 2026 |
| Peptide PartnersCASE #VI-2026-0295 | X | 2 | 6.9 | 4.9 | 8.9 | 27 Feb 2025 | 20 May 2026 |
| BfflinkCASE #VI-2026-0212 | X | 1 | 6.8 | 6.8 | 6.8 | 28 Mar 2025 | 28 Mar 2025 |
| PeptidologyCASE #VI-2026-0520 | X | 1 | 6.8 | 6.8 | 6.8 | 3 Jun 2025 | 3 Jun 2025 |
| Biolongevity LabsCASE #VI-2026-0442 | X | 2 | 6.6 | 5.6 | 7.6 | 3 Jul 2025 | 19 Jan 2026 |
| SRY LabsCASE #VI-2026-0657 | X | 4 | 6.5 | 5.1 | 8.3 | 13 Feb 2025 | 19 Jan 2026 |
| Hangzhou Mandy BiotechnologyCASE #VI-2026-0695 | X | 1 | 6.5 | 6.5 | 6.5 | 9 Jun 2025 | 9 Jun 2025 |
| EHZ PeptidesCASE #VI-2026-0296 | C | 3 | 6.4 | 5.0 | 7.7 | 9 Jun 2025 | 25 May 2026 |
| UWA Elite PeptidesCASE #VI-2026-0130 | X | 1 | 6.4 | 6.4 | 6.4 | 28 Mar 2025 | 28 Mar 2025 |
| TydesCASE #VI-2026-0493 | X | 2 | 6.2 | 6.2 | 6.3 | 16 Mar 2025 | 20 May 2026 |
| Glamgurcraft Innovations Foreign TradeCASE #VI-2026-0348 | X | 1 | 6.2 | 6.2 | 6.2 | 25 Apr 2025 | 25 Apr 2025 |
| Qingdao Saber Technology Pharma QSTCASE #VI-2026-0467 | X | 1 | 6.2 | 6.2 | 6.2 | 11 Jun 2025 | 11 Jun 2025 |
| Shanghai OuDaXin New Material Technology CenterCASE #VI-2026-0498 | E | 3 | 6.0 | 5.1 | 6.7 | 7 May 2025 | 24 May 2026 |
| Kits4lessCASE #VI-2026-0744 | X | 1 | 5.9 | 5.9 | 5.9 | 3 Jul 2025 | 3 Jul 2025 |
| Peptide WorldwideCASE #VI-2026-0217 | X | 1 | 5.6 | 5.6 | 5.6 | 2 Apr 2025 | 2 Apr 2025 |
| Haikou Mingheng TechnologyCASE #VI-2026-0250 | X | 1 | 5.6 | 5.6 | 5.6 | 2 Jul 2025 | 2 Jul 2025 |
| Oasis PeptidesCASE #VI-2026-0404 | X | 1 | 5.5 | 5.5 | 5.5 | 3 Jun 2025 | 3 Jun 2025 |
| Pure RawzCASE #VI-2026-0767 | X | 2 | 4.9 | 4.3 | 5.6 | 13 Feb 2025 | 23 May 2026 |
| Richards Biotech Simply RichardsCASE #VI-2026-0307 | X | 1 | 4.8 | 4.8 | 4.8 | 3 Jun 2025 | 3 Jun 2025 |
| Nanjing Xiyuxun Technology XYXCASE #VI-2026-0433 | X | 1 | 4.7 | 4.7 | 4.7 | 25 Apr 2025 | 25 Apr 2025 |
| Quenna PMQCASE #VI-2026-0415 | X | 1 | 4.4 | 4.4 | 4.4 | 13 Feb 2025 | 13 Feb 2025 |
| Peptide GurusCASE #VI-2026-0854 | X | 2 | 4.2 | 3.2 | 5.2 | 17 Dec 2024 | 20 May 2026 |
| Alimo PeptideCASE #VI-2026-0524 | X | 1 | 3.5 | 3.5 | 3.5 | 16 Mar 2025 | 16 Mar 2025 |
| Kerisite Shenzhen InternationalCASE #VI-2026-0315 | X | 1 | 3.3 | 3.3 | 3.3 | 27 Feb 2025 | 27 Feb 2025 |
| Swiss ChemsCASE #VI-2026-0030 | X | 1 | 2.9 | 2.9 | 2.9 | 8 Jul 2025 | 8 Jul 2025 |
| SubQ SocietyCASE #VI-2026-0716 | X | 1 | 2.3 | 2.3 | 2.3 | 3 Jul 2025 | 3 Jul 2025 |
| Guangzhou Lengiuanhuang CosmeticsCASE #VI-2026-0228 | X | 1 | 1.8 | 1.8 | 1.8 | 2 Apr 2025 | 2 Apr 2025 |
| PRIVATECASE #VI-2026-0635 | X | 1 | 0.4 | 0.4 | 0.4 | 3 Jul 2025 | 3 Jul 2025 |
| Wuhan Newtop BiotechCASE #VI-2026-0676 | X | 1 | 0.0 | 0.0 | 0.0 | 3 Jul 2025 | 3 Jul 2025 |
| Advanced Technology and IndustrialCASE #VI-2026-0133 | X | 1 | 0.0 | 0.0 | 0.0 | 21 May 2025 | 21 May 2025 |
Open any subject to view the batch-level evidence for MT-1 alone.